The increase is moderate in cancer cells, such as SaOs cells, whereas it is highly efficient in noncancer cells, for example in the IMR90 cell line, probably due to the fact that ICBP90 is already expressed at a high level before E2F-1 overexpression. Here, E2F1 is linked to cancer.